Adaptive Biotechnologies has appointed Robert Hershberg to its board of directors. Hershberg is CEO, board member, and co-founder of VentiRx Pharamaceuticals, and he previously was senior vice president and chief medical officer at Dendreon, an assistant professor at Harvard Medical School, and an associate physician at Brigham and Women's Hospital.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.